Innoplexus is a leading global AI
champion with over 300 employees and 100+ patent applications in artificial
intelligence, machine learning, and blockchain technologies. Innoplexus applies
its proprietary tech stack in all stages of the drug development value chain
via smart Data as a Service (DaaS) and Continuous Analytics as a Service (CAaS)
solutions. Generating real-time insights from hundreds of terabytes of
structured and unstructured private and public data, Innoplexus helps
organizations move towards continuous decision-making. Founded in 2015,
Innoplexus AG is headquartered in Eschborn, Germany, with offices in Pune,
India, and Hoboken, United States. More information at http://www.innoplexus.com.